Virtual Screening of Piperidine Based Small Molecules Against COVID-19

Authors

  • Hira Khalid Department of Chemistry, Forman Christian College University, Lahore-54000, Pakistan https://orcid.org/0000-0001-8857-9683
  • Rashid Hussain Department of Chemistry, Forman Christian College University, Lahore-54000, Pakistan
  • Ahmed Hafeez School of Biological Sciences, Forman Christian College University, Lahore-54000, Pakistan

DOI:

https://doi.org/10.22034/labinsilico20012050

Keywords:

COVID-19, Corona virus, Piperidine, Virtual screening

Abstract

COVID-19 was declared a global pandemic in March 2020. Due to urgency with less time, there was a need to explore the potential treatment to address this severe health issue. Drug design and development is a long procedure; therefore, the first approach to speed up the drug development is almost repurposing existing drugs and small molecules.  Over past few decades, use of fast and inexpensive computer-aided drug design (CADD) turned out to be a revolution in the pharmaceutical industry. CADD could help to knock out many inactive compounds at different test stages leading to time and money saving. Moreover, it could help to test already existing small molecules for other diseases. Within this work, an in-house library of 210 biologically active compounds was subjected to in silico virtual screening against COVID-19. The top 10 compounds from docking studies were further tested for in silico ADME prediction using Molinspiration.

References

Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270-2733.

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with Pneumonia in China, 2019. N Engl J Med. 2020;382:727-733.

Harismah K, Mirzaei M. COVID-19?: A serious warning for emergency health innovation. Adv J Sci Eng. 2020;1:32-33.

Ozkendir OM, Askar M, Kocer NE. Influence of the epidemic COVID-19: An outlook on health, business and scientific studies. Lab-in-Silico. 2020;1:26-30.

Yang P, Wang X. COVID-19: a new challenge for human beings. Cell Mol Immunol. 2020;17:555-557.

Yadav A, Mohite S. A review on nNovel coronavirus (COVID-19). Int J Pharma Sci Res. 2020;11: 74-76.

Masters PS. Coronavirus genomic RNA packaging. Virolog. 2019;537:198–207.

Lo C, Tsai T, Lin C, Lin C, Wu H. Interaction of coronavirus nucleocapsid protein with the 5?? and 3??ends of the coronavirus genome is involved in genome circularization and negative?strand RNA synthesis. FEBS J. 2019;286:3222-3239.

Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review. J Am Med Assoc. 2020;323:1824-1836.

Morse JS, Lalonde T, Xu S, Liu WR. Learning from the Past: Possible urgent prevention and treatment options for severe acute respiratory infections caused by 2019-nCoV. ChemBioChem. 2020;21:730-738.

Sliwoski G, Kothiwale S, Meiler J, Lowe EW. Computational methods in drug discovery. Pharmacol Rev Am Soc Pharmacol Exp Therapeut. 2014;66:334-395.

Mirzaei M, Harismah K, Da’I M, Salarrezaei E, Roshandel Z. Screening efficacy of available HIV protease inhibitors on COVID-19 protease. J Mil Med. 2020;22:100-107.

Farahbakhsh Z, Zamani MR, Rafienia M, Gülseren O, Mirzaei M. In silico activity of AS1411 aptamer against nucleolin of cancer cells. Iran J Blood Cancer. 2020;12:95-100.

Mirzaei M. In silico Iinteractions of steviol with monoamine oxidase enzymes. Lab-in-Silico. 2020;1:3-6.

Khalid H, Aziz-ur-Rehman, Abbasi MA, Malik A, Rasool S, Nafeesa K, et al. Synthesis, spectral analysis and anti-bacterial study of N-substituted derivatives of 2-(5-(1-(phenylsulfonyl)piperidin-4-yl)-1,3,4-oxadiazol-2-ylthio)acetamide. J Saudi Chem Soc. 2016;20:S615-2623.

Khalid H, Aziz-ur-Rehman, Abbasi MA, Hussain R, Mohammad Khan K, Ashraf M, et al. Synthesis, biological evaluation, and molecular docking of $N’’$-(Aryl/alkylsulfonyl)-1-(phenylsulfonyl) piperidine-4-carbohydrazide derivatives. Turkish J Chem. 2014;38:189-201.

Bourne PE. The protein data bank. Protein struct. 2003;389-406.

Cosconati S, Forli S, Perryman AL, Harris R, Goodsell DS, Olson AJ. Virtual screening with AutoDock: theory and practice. Expert Opin Drug Discov. 2010;5:597-607.

Khalid H, Aziz-ur-Rehman A, Abbasi MA, Siddiqui SZ, Malik A, Ashraf M, et al. Synthesis of some new biologically active N-substituted-2’’-[(phenylsulfonyl)(piperidin-1-yl)amino]acetamide derivatives. Pak J Pharm Sci. 2014;27:517-524.

Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31:455-461.

Downloads

Published

2020-12-30

How to Cite

Khalid, H., Hussain, R., & Hafeez, A. (2020). Virtual Screening of Piperidine Based Small Molecules Against COVID-19. Lab-in-Silico, 1(2), 50–55. https://doi.org/10.22034/labinsilico20012050

Issue

Section

Original Research Article